| Literature DB >> 28279571 |
Akiko Shimamoto1, Virginie Rappeneau2.
Abstract
The prevalence of some mental illnesses, including major depression, anxiety-, trauma-, and stress-related disorders, some substance use disorders, and later onset of schizophrenia, is higher in women than men. While the higher prevalence in women could simply be explained by socioeconomic determinants, such as income, social status, or cultural background, extensive studies show sex differences in biological, pharmacokinetic, and pharmacological factors contribute to females' vulnerability to these mental illnesses. In this review, we focus on estrogens, chronic stress, and neurotoxicity from behavioral, pharmacological, biological, and molecular perspectives to delineate the sex differences in these mental illnesses. Particularly, we investigate a possible role of mitochondrial function, including biosynthesis, bioenergetics, and signaling, on mediating the sex differences in psychiatric disorders.Entities:
Keywords: Anxiety; Major depression; Mitochondria; Schizophrenia; Sex difference; Substance use disorders
Mesh:
Year: 2017 PMID: 28279571 PMCID: PMC5581986 DOI: 10.1016/j.schres.2017.02.025
Source DB: PubMed Journal: Schizophr Res ISSN: 0920-9964 Impact factor: 4.939